Has Opal Patel received payments from drug or device companies?

Yes. Drug and device makers reported $5,399 in general payments to Opal Patel across 96 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Opal Patel did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Opal Patel come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Opal Patel

Foot & Ankle Surgery · Lakewood, CANPI 1114547056

Payments from drug & device makers

$5,399in general payments, 2019–2025

Across 96 payments — averaging $56.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$2K
Biotissue Holdings Inc.$978
Integra Lifesciences Corporation$459
Mimedx Group, Inc.$397
Smith+Nephew$257
Bioventus LLC$192
plus $1K from 15 others

What the payments were for

Travel & lodging$1,21623%
Food & beverage$4,18377%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	13	$2,044
Biotissue Holdings Inc.	16	$978
Integra Lifesciences Corporation	6	$459
Mimedx Group, Inc.	22	$397
Smith+Nephew	5	$257
Bioventus LLC	6	$192
Innovation Technologies Inc	2	$175
Organogenesis Inc.	4	$152
Paragon 28, Inc.	1	$143
Amgen	1	$122
AbbVie	5	$100
Treace Medical Concepts, Inc.	2	$92
Averitas Pharma Inc.	2	$62
Stimlabs LLC	2	$41
Solventum Corporation	2	$37
Johnson & Johnson	1	$37
Paratek Pharmaceuticals, Inc.	2	$34
Dynasplint Systems Inc.	1	$24
Abbott	1	$21
Access Pro Medical, LLC	1	$19
Orthofix Medical, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

PROstep$1,482
INTEGRA$757
INTEGRA DERMAL REGENERATION TEMPLATE$252
PRIMATRIX$252
ORTHOLOC 3DI$167
Irrisept$157
PICO$145
Grappler$143
KRYSTEXXA$122
VARIAX$118

How this compares

$5,399 in reported general payments places this provider in the 70th percentile of 1,126 foot & ankle surgery providers in California.

See all foot & ankle surgery providers in California →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ketoconazole	121	$3,021
Ciclopirox	46	$2,694
Diclofenac Sodium	14	$345
Doxycycline Hyclate	38	$225
Ammonium Lactate	14	$200
Triamcinolone Acetonide	20	$158
Mupirocin	18	$129
Gabapentin	12	$21
Meloxicam	12	$6

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Lakewood

John ZimmermanBakersfield$4.6M
Eric GizaSacramento$3.7M
Thomas HarrisPasadena$3M
Felix SigalLos Angeles$2.2M
Thomas ChangSanta Rosa$2.1M
Michael CoughlinSan Francisco$1.6M
Vladimir ZeetserEncino$677K
Jason NowakRedding$526K
Candice BradyCamarillo$462K
Andrew HsuOrange$456K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →